An advanced optical imaging technique coupled with an artificial intelligence algorithm has been demonstrated to accurately detect brain tumors, according to a recent study.
A mouse study has demonstrated that glioblastoma could be treated directly using an ultrasound technique that delivers a potent treatment across the blood–brain barrier into the tumor.
Scientists have discovered that an artificial intelligence program, coupled with the chemical analysis of blood samples, could speed up brain tumor diagnosis.
A blood test that measures the amount of cfDNA has been indicated to be correlated with how patients will progress following a glioblastoma diagnosis.
High-grade gliomas may be able to wire themselves into the healthy brain, receiving and interpreting electrical signals from normal neurons.
A blood test for glioblastoma may be on the horizons, as researchers identify novel biomarkers that could be used for diagnosis.
A Phase I clinical trial presents veledimex – a drug-inducible gene therapy approach – as a promising treatment technique for glioblastoma.
Androgen deprivation therapy has been associated with a higher likelihood of developing dementia in men with prostate cancer when compared with individuals who are not exposed to the treatment.
A 65-year follow-up study of approximately 7000 multiple sclerosis patients has uncovered that overall, patients are 14% more likely to develop cancer compared to individuals without the disease.
Enrollment in all ongoing Depatux-M studies has been halted for newly diagnosed glioblastoma due to lack of survival benefit.